Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    22005709 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A New Prenatal Blood Test for Down Syndrome
Conditions: Down Syndrome;   Trisomy 21
Intervention:
2 Recruiting Prenatal Screening for Down Syndrome With DNAFirst
Conditions: Trisomy 21;   Trisomy 18;   Trisomy 13;   Monosomy X
Intervention:
3 Recruiting High Risk Multiple Gestation Study
Conditions: Trisomy 13;   Trisomy 18;   Trisomy 21;   Sex Chromosome Abnormalities
Intervention:
4 Active, not recruiting Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
Conditions: Aneuploidy;   Down Syndrome;   Noninvasive Prenatal Screening
Intervention: Device: SEQureDx Trisomy Test
5 Recruiting Multiple Gestation Study
Conditions: Trisomy 13;   Trisomy 18;   Trisomy 21;   Sex Chromosome Abnormalities
Intervention:
6 Active, not recruiting Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
Conditions: Down Syndrome;   Fetal Aneuploidy
Intervention:

Indicates status has not been verified in more than two years